Biogen Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biogen Inc with three other
companies in this sector in the United States:
Gilead Sciences, Inc.
sales of $22.13 billion
of which 22%
was Ranexa & Other),
of which 78%
was Bioscience), and
of which 21%
Biogen Inc reported sales of $13.45 billion
December of 2018.
increase of 9.6%
versus 2017, when the company's sales were $12.27 billion.
Sales at Biogen Inc have increased during each of the previous five years
(and since 2013, sales have increased a total of 94%).